- Home
- HCTI vs BIAF Comparison
HCTI vs BIAF Comparison
Compare HCTI & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCTI
- BIAF
- Stock Information
- Founded
- HCTI 2020
- BIAF 2014
- Country
- HCTI United States
- BIAF United States
- Employees
- HCTI N/A
- BIAF N/A
- Industry
- HCTI Retail: Computer Software & Peripheral Equipment
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HCTI Technology
- BIAF Health Care
- Exchange
- HCTI Nasdaq
- BIAF Nasdaq
- Market Cap
- HCTI 13.5M
- BIAF 12.2M
- IPO Year
- HCTI 2021
- BIAF 2022
- Fundamental
- Price
- HCTI $0.05
- BIAF $0.33
- Analyst Decision
- HCTI
- BIAF Hold
- Analyst Count
- HCTI 0
- BIAF 1
- Target Price
- HCTI N/A
- BIAF N/A
- AVG Volume (30 Days)
- HCTI 506.0M
- BIAF 2.3M
- Earning Date
- HCTI 08-18-2025
- BIAF 08-13-2025
- Dividend Yield
- HCTI N/A
- BIAF N/A
- EPS Growth
- HCTI N/A
- BIAF N/A
- EPS
- HCTI N/A
- BIAF N/A
- Revenue
- HCTI $11,291,000.00
- BIAF $8,809,228.00
- Revenue This Year
- HCTI N/A
- BIAF N/A
- Revenue Next Year
- HCTI N/A
- BIAF $20.00
- P/E Ratio
- HCTI N/A
- BIAF N/A
- Revenue Growth
- HCTI N/A
- BIAF 78.40
- 52 Week Low
- HCTI $0.01
- BIAF $0.16
- 52 Week High
- HCTI $1.90
- BIAF $2.75
- Technical
- Relative Strength Index (RSI)
- HCTI 61.78
- BIAF 53.46
- Support Level
- HCTI $0.05
- BIAF $0.33
- Resistance Level
- HCTI $0.09
- BIAF $0.36
- Average True Range (ATR)
- HCTI 0.01
- BIAF 0.03
- MACD
- HCTI 0.01
- BIAF 0.00
- Stochastic Oscillator
- HCTI 55.07
- BIAF 61.14
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.